NCT07729852: Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France
- State
- Under way
- Phase
- Phase 2
- People
- 7 planned
- Started
- 1 Oct 2026
- Primary completion
- Jul 2029
- Arms
- ATH434 75mg BID
- Results
- None posted
- 28 Jul 2026: Trial registered
- 1 Oct 2026: Trial started